Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Medicamen Organics Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹0.00
High
₹0.00
Price Summary
| Previous Close | ₹24.40 |
|---|---|
| Day's Range | ₹0.00 - ₹0.00 |
| Open | ₹0.00 |
| 52 Week Range | ₹19.10 - ₹41.00 |
| Volume | 0 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -3.30 |
| P/E Ratio | 6.27 |
| Book Value(₹) | 0.99 |
| PAT Margin (%) | 10.60 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 16.97 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 370.88 |
| Expenses | N/A | N/A |
| PBT | N/A | 43.87 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 32.71 |
About Medicamen Organics Ltd.
| Founded | 1995 |
|---|---|
| Managing Director | Bal Kishan Gupta |
| NSE Symbol | MEDIORG |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,65,470.98 | 1,938.45 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,26,630.53 | 8,594.10 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,157.37 | 4,876.60 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,25,825.95 | 8,567.85 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,108.13 | 1,465.05 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,17,705.45 | 1,201.95 | 835.50 - 835.50 |
| Lupin Ltd. | 1,04,158.11 | 2,259.70 | 1,875.00 - 1,875.00 |
| Lenskart Solutions Ltd. | 1,02,419.34 | 590.00 | 0.00 - 0.00 |
| Max Healthcare Institute Ltd. | 1,01,220.44 | 1,009.65 | 903.00 - 903.00 |
| Dr. Reddy's Laboratories Ltd. | 1,00,578.43 | 1,202.20 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Aug
12
2026
Posted on Aug 12th 2026
Prevest Denpro - Quaterly Results
The Revenue for the quarter ended June 2026 of Rs. 194.43 millions grew by 23.66 % from Rs. 157.23 millions.Net profit stood at Rs. 57.83 millions compared to Rs. 46.33 millions in the corresponding previous quarter,high by 24.82%.Operating profit for the quarter ended June 2026 rose to 82.19 millions as compared to 67.03 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 194.43 | 157.23 | 23.66 | 194.43 | 157.23 | 23.66 | 716.64 | 630.68 | 13.63 |
| Other Income | 13.31 | 11.73 | 13.47 | 13.31 | 11.73 | 13.47 | 49.97 | 41.10 | 21.58 |
| PBIDT | 82.19 | 67.03 | 22.62 | 82.19 | 67.03 | 22.62 | 305.33 | 261.76 | 16.65 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 82.19 | 67.03 | 22.62 | 82.19 | 67.03 | 22.62 | 305.33 | 261.76 | 16.65 |
| Depreciation | 5.16 | 4.90 | 5.31 | 5.16 | 4.90 | 5.31 | 19.92 | 19.02 | 4.73 |
| PBT | 77.03 | 62.13 | 23.98 | 77.03 | 62.13 | 23.98 | 285.41 | 242.74 | 17.58 |
| TAX | 19.20 | 15.80 | 21.52 | 19.20 | 15.80 | 21.52 | 71.22 | 60.71 | 17.31 |
| Deferred Tax | 0.46 | 0.59 | -22.03 | 0.46 | 0.59 | -22.03 | 2.56 | 3.08 | -16.88 |
| PAT | 57.83 | 46.33 | 24.82 | 57.83 | 46.33 | 24.82 | 214.19 | 182.03 | 17.67 |
| Equity | 120.03 | 120.03 | 0.00 | 120.03 | 120.03 | 0.00 | 120.03 | 120.03 | 0.00 |
| PBIDTM(%) | 42.27 | 42.63 | -0.84 | 42.27 | 42.63 | -0.84 | 42.61 | 41.50 | 2.65 |
Read More
Aug
12
2026
Posted on Aug 12th 2026
Unichem Laboratories - Quaterly Results
A slight decline in the revenue of Rs. 3662.70 millions was seen for the June 2026 quarter as against Rs. 3842.50 millions during year-ago period.The Total Profit for the quarter ended June 2026 of Rs. 55.30 millions grew from Rs.-18.50 millionsOperating profit for the quarter ended June 2026 rose to 373.60 millions as compared to 299.90 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3662.70 | 3842.50 | -4.68 | 3662.70 | 3842.50 | -4.68 | 14122.90 | 17357.00 | -18.63 |
| Other Income | 167.20 | 42.50 | 293.41 | 167.20 | 42.50 | 293.41 | 629.00 | 408.30 | 54.05 |
| PBIDT | 373.60 | 299.90 | 24.57 | 373.60 | 299.90 | 24.57 | 1132.60 | 2947.10 | -61.57 |
| Interest | 12.90 | 19.30 | -33.16 | 12.90 | 19.30 | -33.16 | 118.00 | 76.20 | 54.86 |
| PBDT | 360.70 | 280.60 | 28.55 | 360.70 | 280.60 | 28.55 | 3284.40 | 2910.90 | 12.83 |
| Depreciation | 286.90 | 299.30 | -4.14 | 286.90 | 299.30 | -4.14 | 1190.30 | 1084.10 | 9.80 |
| PBT | 73.80 | -18.70 | -494.65 | 73.80 | -18.70 | -494.65 | 2094.10 | 1826.80 | 14.63 |
| TAX | 18.50 | -0.20 | -9350.00 | 18.50 | -0.20 | -9350.00 | 504.70 | 197.20 | 155.93 |
| Deferred Tax | 18.50 | -4.60 | -502.17 | 18.50 | -4.60 | -502.17 | 500.30 | 197.20 | 153.70 |
| PAT | 55.30 | -18.50 | -398.92 | 55.30 | -18.50 | -398.92 | 1589.40 | 1629.60 | -2.47 |
| Equity | 140.80 | 140.80 | 0.00 | 140.80 | 140.80 | 0.00 | 140.80 | 140.80 | 0.00 |
| PBIDTM(%) | 10.20 | 7.80 | 30.69 | 10.20 | 7.80 | 30.69 | 8.02 | 16.98 | -52.77 |
Read More
Aug
12
2026
Posted on Aug 12th 2026
Nephrocare Health - Quaterly Results
The June 2026 quarter revenue stood at Rs. 1703.78 millions, up 14.48% as compared to Rs. 1488.26 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 125.63 millions from Rs. 50.14 millions in the quarter ended June 2026.The company reported a good operating profit of 302.66 millions compared to 227.22 millions of corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1703.78 | 1488.26 | 14.48 | 1703.78 | 1488.26 | 14.48 | 6297.43 | 5435.97 | 15.85 |
| Other Income | 61.24 | 29.72 | 106.06 | 61.24 | 29.72 | 106.06 | 154.34 | 156.31 | -1.26 |
| PBIDT | 302.66 | 227.22 | 33.20 | 302.66 | 227.22 | 33.20 | 1036.01 | 1105.14 | -6.26 |
| Interest | 4.85 | 34.78 | -86.06 | 4.85 | 34.78 | -86.06 | 497.61 | 142.99 | 248.00 |
| PBDT | 297.81 | 192.44 | 54.75 | 297.81 | 192.44 | 54.75 | 538.40 | 962.15 | -44.04 |
| Depreciation | 130.88 | 123.46 | 6.01 | 130.88 | 123.46 | 6.01 | 576.09 | 508.55 | 13.28 |
| PBT | 166.93 | 68.98 | 142.00 | 166.93 | 68.98 | 142.00 | -37.69 | 453.60 | -108.31 |
| TAX | 41.30 | 18.84 | 119.21 | 41.30 | 18.84 | 119.21 | 42.91 | 111.24 | -61.43 |
| Deferred Tax | -19.41 | -7.83 | 147.89 | -19.41 | -7.83 | 147.89 | -98.29 | 30.28 | -424.60 |
| PAT | 125.63 | 50.14 | 150.56 | 125.63 | 50.14 | 150.56 | -80.60 | 342.36 | -123.54 |
| Equity | 200.68 | 36.18 | 454.67 | 200.68 | 36.18 | 454.67 | 200.68 | 17.65 | 1037.00 |
| PBIDTM(%) | 17.76 | 15.27 | 16.35 | 17.76 | 15.27 | 16.35 | 16.45 | 20.33 | -19.08 |
Read More
Aug
12
2026
Posted on Aug 12th 2026
Viyash Scientific - Quaterly Results
The June 2026 quarter revenue stood at Rs. 3536.90 millions, up 7.77% as compared to Rs. 3281.80 millions during the corresponding quarter last year.A humble growth in net profit of 20.92% reported in the quarter ended June 2026 to Rs. 209.20 millions from Rs. 173.00 millions.A decline of 617.40 millions was observed in the OP in the quarter ended June 2026 from 623.50 millions on QoQ basis.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3536.90 | 3281.80 | 7.77 | 3536.90 | 3281.80 | 7.77 | 13820.60 | 13103.40 | 5.47 |
| Other Income | 145.90 | 129.00 | 13.10 | 145.90 | 129.00 | 13.10 | 662.60 | 722.10 | -8.24 |
| PBIDT | 617.40 | 623.50 | -0.98 | 617.40 | 623.50 | -0.98 | 3007.90 | 2805.00 | 7.23 |
| Interest | 14.40 | 60.20 | -76.08 | 14.40 | 60.20 | -76.08 | 162.10 | 251.40 | -35.52 |
| PBDT | 603.00 | 550.80 | 9.48 | 603.00 | 550.80 | 9.48 | 2403.70 | 1738.90 | 38.23 |
| Depreciation | 324.10 | 308.90 | 4.92 | 324.10 | 308.90 | 4.92 | 1241.50 | 1247.20 | -0.46 |
| PBT | 278.90 | 241.90 | 15.30 | 278.90 | 241.90 | 15.30 | 1162.20 | 491.70 | 136.36 |
| TAX | 69.70 | 68.90 | 1.16 | 69.70 | 68.90 | 1.16 | 403.50 | -93.20 | -532.94 |
| Deferred Tax | 23.50 | -43.20 | -154.40 | 23.50 | -43.20 | -154.40 | 251.40 | -490.10 | -151.30 |
| PAT | 209.20 | 173.00 | 20.92 | 209.20 | 173.00 | 20.92 | 758.70 | 584.90 | 29.71 |
| Equity | 873.70 | 500.70 | 74.50 | 873.70 | 500.70 | 74.50 | 873.70 | 500.60 | 74.53 |
| PBIDTM(%) | 17.46 | 19.00 | -8.12 | 17.46 | 19.00 | -8.12 | 21.76 | 21.41 | 1.67 |
Read More
Aug
12
2026
Posted on Aug 12th 2026
Lactose (India) - Quaterly Results
A fair growth of 18.68% in the revenue at Rs. 469.68 millions was reported in the June 2026 quarter as compared to Rs. 395.76 millions during year-ago period.Net profit for the quarter ended June 2026 increased significantly by 57.77% to Rs. 23.65 millions from Rs. 14.99 millions.Operating profit surged to 66.35 millions from the corresponding previous quarter of 48.82 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 469.68 | 395.76 | 18.68 | 469.68 | 395.76 | 18.68 | 1632.90 | 1163.99 | 40.28 |
| Other Income | 5.60 | 4.15 | 34.94 | 5.60 | 4.15 | 34.94 | 10.72 | 14.54 | -26.27 |
| PBIDT | 66.35 | 48.82 | 35.91 | 66.35 | 48.82 | 35.91 | 194.49 | 184.12 | 5.63 |
| Interest | 17.64 | 12.20 | 44.59 | 17.64 | 12.20 | 44.59 | 50.86 | 61.03 | -16.66 |
| PBDT | 48.71 | 36.62 | 33.01 | 48.71 | 36.62 | 33.01 | 143.63 | 123.09 | 16.69 |
| Depreciation | 16.38 | 13.73 | 19.30 | 16.38 | 13.73 | 19.30 | 57.42 | 53.91 | 6.51 |
| PBT | 32.33 | 22.89 | 41.24 | 32.33 | 22.89 | 41.24 | 86.21 | 69.18 | 24.62 |
| TAX | 8.68 | 7.90 | 9.87 | 8.68 | 7.90 | 9.87 | 25.58 | 17.54 | 45.84 |
| Deferred Tax | 1.92 | 4.08 | -52.94 | 1.92 | 4.08 | -52.94 | 13.40 | 4.38 | 205.94 |
| PAT | 23.65 | 14.99 | 57.77 | 23.65 | 14.99 | 57.77 | 60.63 | 51.64 | 17.41 |
| Equity | 125.89 | 125.89 | 0.00 | 125.89 | 125.89 | 0.00 | 125.89 | 125.89 | 0.00 |
| PBIDTM(%) | 14.13 | 12.34 | 14.52 | 14.13 | 12.34 | 14.52 | 11.91 | 15.82 | -24.70 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Medicamen Organics Ltd. is ₹24.40 as of 2026-08-12.
The market capitalisation of Medicamen Organics Ltd. is ₹29.68 as of 2026-08-11.
The 1-year return of Medicamen Organics Ltd. is -9.65% as of 2026-08-12.
The P/E ratio of Medicamen Organics Ltd. is 6.27 as of 2026-08-12.
The 52-week high and low of Medicamen Organics Ltd. are ₹41.00 and ₹19.10, respectively, as of 2026-08-12.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
